Rajan Anand

469 total citations
5 papers, 166 citations indexed

About

Rajan Anand is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Rheumatology. According to data from OpenAlex, Rajan Anand has authored 5 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cardiology and Cardiovascular Medicine, 2 papers in Oncology and 2 papers in Rheumatology. Recurrent topics in Rajan Anand's work include Rheumatoid Arthritis Research and Therapies (2 papers), Computational Drug Discovery Methods (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Rajan Anand is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (2 papers), Computational Drug Discovery Methods (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Rajan Anand collaborates with scholars based in United States. Rajan Anand's co-authors include Gregory R. Ott, James M. Trzăskos, Zhonghui Lu, Mingxin Qian, James J.‐W. Duan, David D. Christ, Robert Newton, Rui‐Qin Liu, Krishna Vaddi and Maryanne Covington and has published in prestigious journals such as Bioorganic & Medicinal Chemistry Letters, ChemBioChem and ACS Medicinal Chemistry Letters.

In The Last Decade

Rajan Anand

5 papers receiving 165 citations

Peers

Rajan Anand
Anita J. Kempf-Grote United States
Takashi Imada Japan
Jitendra K. Mishra India
Antonio Mete United Kingdom
Yuri Bukhtiyarov United States
Zili Xiao United States
Shuqun Lin United States
Abel Silva‐Garcia United States
Leslie Leith United States
C. Hamlett United Kingdom
Anita J. Kempf-Grote United States
Rajan Anand
Citations per year, relative to Rajan Anand Rajan Anand (= 1×) peers Anita J. Kempf-Grote

Countries citing papers authored by Rajan Anand

Since Specialization
Citations

This map shows the geographic impact of Rajan Anand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajan Anand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajan Anand more than expected).

Fields of papers citing papers by Rajan Anand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajan Anand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajan Anand. The network helps show where Rajan Anand may publish in the future.

Co-authorship network of co-authors of Rajan Anand

This figure shows the co-authorship network connecting the top 25 collaborators of Rajan Anand. A scholar is included among the top collaborators of Rajan Anand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajan Anand. Rajan Anand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Lam, Pui‐Ying, Peter S. Kutchukian, Rajan Anand, et al.. (2020). Cyp1 Inhibition Prevents Doxorubicin‐Induced Cardiomyopathy in a Zebrafish Heart‐Failure Model. ChemBioChem. 21(13). 1905–1910. 20 indexed citations
2.
Wilson, Jonathan E., Ravi Kurukulasuriya, Mikhail Reibarkh, et al.. (2016). Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach. ACS Medicinal Chemistry Letters. 7(3). 261–265. 43 indexed citations
3.
Deng, Qiaolin, Yeon‐Hee Lim, Rajan Anand, et al.. (2015). Use of molecular modeling aided design to dial out hERG liability in adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2958–2962. 9 indexed citations
4.
Lu, Zhonghui, Gregory R. Ott, Rajan Anand, et al.. (2008). Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE): Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituents. Bioorganic & Medicinal Chemistry Letters. 18(6). 1958–1962. 53 indexed citations
5.
Ott, Gregory R., Naoyuki Asakawa, Zhonghui Lu, et al.. (2008). Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1′ substituents. Bioorganic & Medicinal Chemistry Letters. 18(5). 1577–1582. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anita J. Kempf-Grote Breakdown of academic impact, for papers by Takashi Imada Breakdown of academic impact, for papers by Jitendra K. Mishra Breakdown of academic impact, for papers by Antonio Mete Breakdown of academic impact, for papers by Yuri Bukhtiyarov Breakdown of academic impact, for papers by Zili Xiao Breakdown of academic impact, for papers by Shuqun Lin Breakdown of academic impact, for papers by Abel Silva‐Garcia Breakdown of academic impact, for papers by Leslie Leith Breakdown of academic impact, for papers by C. Hamlett
Rankless by CCL
2026